Adverse reaction signal ratio imbalance analysis of the rare disease drug efgartigimod α based on the FDA adverse event reporting system database

Lingna GAO, Zongyun LI, Xiaoli ZHU, Jingzhe HAN

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (8) : 74-80.

PDF(705 KB)
Welcome to visit Clinical Medication Journal!
PDF(705 KB)
Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (8) : 74-80. DOI: 10.3969/j.issn.1672-3384.2025.08.013
Original Article

Adverse reaction signal ratio imbalance analysis of the rare disease drug efgartigimod α based on the FDA adverse event reporting system database

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 23(8): 74-80 https://doi.org/10.3969/j.issn.1672-3384.2025.08.013

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(705 KB)

Accesses

Citation

Detail

Sections
Recommended

/